Type / Class
Equity / Class A common stock, par value $0.0001 per share
Shares outstanding
1,261,821
Total 13F shares
3,015,414
Share change
+813,441
Total reported value
$33,611,838
Price per share
$11.19
Number of holders
17
Value change
+$9,084,045
Number of buys
6
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP G6256B106?
CUSIP G6256B106 identifies DNQAF - Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of DNQAF - Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
class O/S missing
470,000
$4,111,560 31 Mar 2024
13F
Calamos Advisors LLC
13F
Company
mixed-class rows
700,000
mixed-class rows
$3,881,308 31 Mar 2024
13F
GLAZER CAPITAL, LLC
13F
Company
25%
310,944
$3,430,000 31 Mar 2024
13F
KIM, LLC
13F
Company
20%
247,252
$2,732,135 31 Mar 2024
13F
Westchester Capital Management, LLC
13F
Company
18%
224,555
$2,485,824 31 Mar 2024
13F
Crossingbridge Advisors, LLC
13F
Company
15%
189,544
$2,098,252 31 Mar 2024
13F
Centiva Capital, LP
13F
Company
15%
187,764
$2,080,425 31 Mar 2024
13F
BERKLEY W R CORP
13F
Company
18%
224,632
$1,954,298 31 Mar 2024
13F
MANGROVE PARTNERS IM, LLC
13F
Company
class O/S missing
195,103
$1,706,761 31 Mar 2024
13F
Karpus Management, Inc.
13F
Company
11%
137,050
$1,517,144 31 Mar 2024
13F
PERISCOPE CAPITAL INC.
13F
Company
mixed-class rows
324,500
mixed-class rows
$1,391,411 31 Mar 2024
13F
Quarry LP
13F
Company
7.9%
99,781
$1,120,541 31 Mar 2024
13F
Yakira Capital Management, Inc.
13F
Company
mixed-class rows
190,000
mixed-class rows
$1,055,302 31 Mar 2024
13F
Dakota Wealth Management
13F
Company
0.79%
10,000
$87,480 31 Mar 2024
13F
Polar Asset Management Partners Inc.
13F
Company
class O/S missing
1,400,000
$53,830 31 Mar 2024
13F
Context Capital Management, LLC
13F
Company
class O/S missing
605,000
$30,855 31 Mar 2024
13F
Shaolin Capital Management LLC
13F
Company
class O/S missing
443,051
$22,595 31 Mar 2024
13F
Hudson Bay Capital Management LP
13F
Company
class O/S missing
396,921
$20,243 31 Mar 2024
13F
Cubist Systematic Strategies, LLC
13F
Company
class O/S missing
393,423
$20,065 31 Mar 2024
13F
Saba Capital Management, L.P.
13F
Company
class O/S missing
410,000
$15,765 31 Mar 2024
13F
Taconic Capital Advisors LP
13F
Company
class O/S missing
257,500
$13,133 31 Mar 2024
13F
D. E. Shaw & Co., Inc.
13F
Company
class O/S missing
225,000
$11,475 31 Mar 2024
13F
WHITEBOX ADVISORS LLC
13F
Company
class O/S missing
200,000
$10,200 31 Mar 2024
13F
COWEN AND COMPANY, LLC
13F
Company
class O/S missing
195,721
$9,981 31 Mar 2024
13F
CLEAR STREET LLC
13F
Company
class O/S missing
180,151
$9,188 31 Mar 2024
13F
Arena Investors LP
13F
Company
class O/S missing
225,000
$8,876 31 Mar 2024
13F
WOLVERINE ASSET MANAGEMENT LLC
13F
Company
class O/S missing
162,419
$8,283 31 Mar 2024
13F
RIVERNORTH CAPITAL MANAGEMENT, LLC
13F
Company
class O/S missing
154,800
$7,895 31 Mar 2024
13F
Lynwood Capital Management Inc.
13F
Company
class O/S missing
104,500
$5,330 31 Mar 2024
13F
Tower Research Capital LLC (TRC)
13F
Company
0.04%
451
$3,945 31 Mar 2024
13F
JPMORGAN CHASE & CO
13F
Company
class O/S missing
259
$2,331 31 Mar 2024
13F
Cable Car Capital, LP
13F
Company
class O/S missing
45,000
$2,295 31 Mar 2024
13F
METEORA CAPITAL, LLC
13F
Company
class O/S missing
68,878
$2,135 31 Mar 2024
13F
III Capital Management
13F
Company
class O/S missing
41,184
$1,583 31 Mar 2024
13F
Schonfeld Strategic Advisors LLC
13F
Company
class O/S missing
20,000
$769 31 Mar 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
class O/S missing
130
$4 31 Mar 2024
13F

Institutional Holders of Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share (DNQAF) as of Q2 2024

As of 30 Jun 2024, Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share (DNQAF) was held by 17 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,015,414 shares. The largest 10 holders included METEORA CAPITAL, LLC, Calamos Advisors LLC, GLAZER CAPITAL, LLC, KIM, LLC, BERKLEY W R CORP, Westchester Capital Management, LLC, Crossingbridge Advisors, LLC, Centiva Capital, LP, AQR Arbitrage LLC, and Karpus Management, Inc.. This page lists 17 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
11
Q2 2024 holders
17
Holder diff
6
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 Value $ Q2 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .